… Despite the strong clinical success of cancer immunotherapy with checkpoint inhibitors and
other immune modulating agents, most patients still do not experience a durable response (…

… innate response must be involved. Another interesting implication of the involvement of innate
immunity in cancer … of Coley's approach to cancer immunotherapy. In this regard, it is now …

… immune cells have been successfully augmented as part of an immunotherapy regimen.
In … immunotherapy of cancer will likely involve components of innate immune stimulation. …

… and also as a potential candidate for cancer immunotherapy. TIM-3 acts as a negative
regulator of NK cell function and its upregulation in cancer patients has been associated with an …

… We will also analyze the peculiarities of the γδ T lymphocyte … the optimal clinical exploitation
of these cells of innate immunity. … these properties and optimize cancer immunotherapy? …

… cancer immunotherapy relies on an alignment of the innate and adaptive arms of the immune
system. A key molecule involved in bridging innate and … Within the innate immune system, …

… In the current rush to advance cancer immunotherapy, innate … failure of cancer
immunotherapies, the role of innate immune … , myeloid leukocytes, and innate lymphocytes are …

… Cancer immunotherapy based on the stimulation of innate … Further improvement of cancer
immunotherapy based on the use of … This innate immunity based cancer immunotherapy was …

… of innate effector mechanisms performed by myeloid cells during cancer development and
progression. Noteworthy, effector mechanisms that are initially deployed by innate myeloid …

… CD56 + CD3 − lymphocytes that constitute 1 component of the innate immune system. NK …
Recent studies have implicated NK cells in bridging the innate and adaptive immune response…